Cargando…

Cariprazine treatment in patients with psychosis related to Parkinson’s Disease: a case report.

INTRODUCTION: Because of their mechanism of action, treatments used in Parkinson’s disease can lead to the development of non-motor symptoms, including neuropsychiatric manifestations such as psychotic symptoms and mood disturbances such as depression. Cariprazine is a new atypical antipsychotic, D3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín De Argila Lorente, M., Ruiz Manrique De Lara, G., González Guembe, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479476/ http://dx.doi.org/10.1192/j.eurpsy.2023.2279

Ejemplares similares

Cariprazine Use in Early Psychosis: Three Case Reports
por: Coentre, Ricardo, et al.
Publicado: (2021)

Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
por: Bajouco, Miguel, et al.
Publicado: (2022)

A Case Report of Treatment With Cariprazine in a Recurrent Psychosis Presumably Induced by Methamphetamine
por: Moran, Robert A, et al.
Publicado: (2023)

Defining the therapeutic reference range for cariprazine
por: Kapás, M., et al.
Publicado: (2023)

Benzodiazepine use during cariprazine treatment in acute schizophrenia
por: Correll, C., et al.
Publicado: (2022)

Use of cariprazine as an impulsivity regulator in an adolescent with non suicidal self-injury and suicidal attempts. Case report
por: Del Sol Calderon, P., et al.
Publicado: (2023)

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report
por: Everte, I., et al.
Publicado: (2022)

Cariprazine as a treatment for negative psychotic symptoms in first-episode psychosis: case series
por: Demjaha, Arsime, et al.
Publicado: (2022)

Cariprazine as a useful treatment for patients with schizophrenia and antipsychotic-induced extrapyramidal symptoms: a case report and literature review
por: Llach, C., et al.
Publicado: (2022)

Case Report: Long-Acting Oral Cariprazine
por: Dyrmishi, Emanuela, et al.
Publicado: (2022)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
por: Darriba, H. Becerra
Publicado: (2021)

Psychosis in Parkinson’s Disease: a Case Report of Diagnosis and Management
por: Andrade, R. P. L., et al.
Publicado: (2023)

Cariprazine pharmacokinetics
Publicado: (2022)

Clozapine use in drug induced psychosis in Parkinson´s disease: a case report and review of literature.
por: Sanz Giancola, A., et al.
Publicado: (2023)

Cariprazine add-on for resistant bipolar depression: preliminary results from an italian real-world experience
por: Martiadis, V., et al.
Publicado: (2023)

Thyroid psychosis: a case report
por: Izquierdo De La Puente, A., et al.
Publicado: (2022)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel, Thomas
Publicado: (2021)

Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
por: Berardis, Domenico De, et al.
Publicado: (2021)

S63. WHICH CLINICAL AND COGNITIVE FACTORS ARE RELATED WITH CHANGES IN JUMPING TO CONCLUSIONS IN FIRST-EPISODE PSYCHOSIS?
por: Ochoa, Susana, et al.
Publicado: (2018)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Clinical effects of Cariprazine and their relationship with polymorphisms of dopamine and serotonin receptors: preliminary results from a prospective study on schizophrenia and bipolar disorder
por: De Pieri, M., et al.
Publicado: (2022)

Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
por: Mcintyre, R., et al.
Publicado: (2022)

The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
por: Falkai, P., et al.
Publicado: (2022)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

Psychosis secondary to indomethacin. A case report
por: González, S. Santiago, et al.
Publicado: (2021)

Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up
por: Pappa, Sofia, et al.
Publicado: (2023)

Case series: Cariprazine in early-onset schizophrenia
por: Ivanova, Elena, et al.
Publicado: (2023)

Levetirazetam psychosis
por: Martín, C. Vilella, et al.
Publicado: (2021)

The Line between Psychosis and Schizotypy: a case report
por: Huerga García, L., et al.
Publicado: (2022)

Is it psychosis? Heads or tails. A case report
por: Rodado León, B., et al.
Publicado: (2022)

Vascular psychosis in the elderly. case report and literature review for different antypsichotic treatment strategies
por: Higueras, T. Gutiérrez, et al.
Publicado: (2021)

Revisiting hysterical psychosis: A case report
por: Barbosa, D., et al.
Publicado: (2021)

PM513. Clinical Pharmacology Study of Cariprazine with Healthy Adult Japanese, Korean, Taiwanese, and Caucasian Male Subjects
por: Morio, Yasunori, et al.
Publicado: (2016)

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
por: McIntyre, R. S., et al.
Publicado: (2023)

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
por: Durgam, Suresh, et al.
Publicado: (2016)

Psychosis as alzheimer disease debut: a case report
por: Vilella Martín, C., et al.
Publicado: (2022)

Post-ictal psychosis: A case report
por: Turki, M., et al.
Publicado: (2021)

F243. INFLUENCE OF METACOGNITION AND IRRATIONAL BELIEFS ON SOCIAL FUNCTIONING IN PSYCHOSIS OF RECENT ONSET
por: García-Mieres, Helena, et al.
Publicado: (2018)

Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior—Successful management with cariprazine
por: Renemane, Lubova, et al.
Publicado: (2023)

Increased risk of psychosis to ivermectin treatment
por: Romero Calderon, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mht6gmsl6mqo6mrvnnkhoq2e6